REGINfo: VIFOR PHARMA - Pharmacie - Financial information

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
> TA 25
Israel - TA 25
- ALONY HETZ
- AZRIELI GROUP
- BAZAN
- BEZEQ
- DELEK DRILLIN
- DISCOUNT
- ELBIT SYSTEMS
- FIBI BANK
- GAZIT GLOBE
- HAREL
- ICL
- IFF
- ISRAEL CORP
- LEUMI
- MAZOR ROBOTICS
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- ORMAT
- PAZ OIL
- PERRIGO
- POALIM
- SHUFERSAL
- SODASTREAM
- STRAUSS GROUP
- TEVA
- TOWER JAZZ

Europe

COMPANY SEARCH RESULT

$VIFOR PHARMA: Click to view the issuer\'s details$

Last update : 21/08/2018 >View issuer details

2019.03.14 | 06:00 | Permanent Information Releases / Sales and Revenues

puce LE GROUPE VIFOR PHARMA PUBLIE DE SOLIDES RÉSULTATS 2018 SUPÉRIEURS AUX PRÉVISIONS - HTML (w)

2019.03.14 | 06:00 | Permanent Information Releases / Sales and Revenues

puce Vifor Pharma Group Reports Strong 2018 Results, Exceeding Raised Guidance - HTML (w)

2019.01.24 | 06:00 | Permanent Information Releases / General Company News

puce ChemoCentryx Announces Withdrawal of Phase II-Based Conditional Marketing Authorisation (CMA) Application for ANCA-Associated Vasculitis in Europe, Phase III Advocate Trial Data Release Planned for Q4 2019 - HTML (w)

2019.01.22 | 06:00 | Permanent Information Releases / General Company News

puce Updated Analysis of Pivotal Study Reveals: Proactive, High Dosage of Venofer® Significantly Reduces Risk of Death or Major Cardiovascular Events in Haemodialysis Patients - HTML (w)

2019.01.07 | 06:00 | Permanent Information Releases / General Company News

puce Vifor Pharma receives positive phase-I trial results for oral ferroportin inhibitor - HTML (w)

2019.01.07 | 06:00 | Permanent Information Releases / General Company News

puce Vifor Pharma obtient des résultats d’essai de phase I positifs pour l’inhibiteur de la ferroportine administré par voie orale - HTML (w)

2018.12.12 | 06:00 | Permanent Information Releases / Appointments

puce Patrick Treanor appointed President of Relypsa and member of the Executive Committee of Vifor Pharma Group - HTML (w)

2018.11.26 | 06:00 | Permanent Information Releases / General Company News

puce 2018 Iron Deficiency Day: A Call to Develop a Better Understanding of Iron Deficiency - HTML (w)

2018.08.08 | Periodic information / Half-Year Financial Report

puce VIFOR PHARMA : HALF-YEAR REPORT 2018 - PDF (746Kb)

2018.03.13 | Periodic information / Annual Financial Report

puce VIFOR PHARMA : ANNUAL REPORT 2017 - PDF (6Mb)